Search research articles
Contact Us
Filters
Showing results (191-200 of 194) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 194 results.
Biochemical Pharmacology
|
February 13, 2001
Enzyme-catalyzed therapeutic agent (ECTA) design: activation of the antitumor ECTA compound NB1011 by thymidylate synthase
D B Lackey, M P Groziak, M Sergeeva, et al.
Journal of Medicinal Chemistry
|
June 23, 1999
Phthalein derivatives as a new tool for selectivity in thymidylate synthase inhibition
P M Costi, M Rinaldi, D Tondi, et al.
Nature
|
October 17, 1998
Efficiency of signalling through cytokine receptors depends critically on receptor orientation
R S Syed, S W Reid, C Li, et al.
Protein Engineering
|
July 2, 1999
Engineering a soluble extracellular erythropoietin receptor (EPObp) in Pichia pastoris to eliminate microheterogeneity, and its complex with erythropoietin
H Zhan, B Liu, S W Reid, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 194) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 194 results.
Biochemical Pharmacology
|
February 13, 2001
Enzyme-catalyzed therapeutic agent (ECTA) design: activation of the antitumor ECTA compound NB1011 by thymidylate synthase
D B Lackey, M P Groziak, M Sergeeva, et al.
Journal of Medicinal Chemistry
|
June 23, 1999
Phthalein derivatives as a new tool for selectivity in thymidylate synthase inhibition
P M Costi, M Rinaldi, D Tondi, et al.
Nature
|
October 17, 1998
Efficiency of signalling through cytokine receptors depends critically on receptor orientation
R S Syed, S W Reid, C Li, et al.
Protein Engineering
|
July 2, 1999
Engineering a soluble extracellular erythropoietin receptor (EPObp) in Pichia pastoris to eliminate microheterogeneity, and its complex with erythropoietin
H Zhan, B Liu, S W Reid, et al.
Page
of 20